Dr William Whiteley (BM BCh MA MSc PhD MRCP)
Scottish Senior Clinical Fellow and Consultant Neurologist
- Centre for Clinical Brain Sciences
Contact details
- Tel: +44 (0)131 537 1089
- Email: william.whiteley@ed.ac.uk
Background
William Whiteley is a Scottish Senior Clinical Fellow (funded by CSO) in the Centre for Clinical Brain Sciences, University of Edinburgh.
He is also Senior Clinical Fellow in the Nuffield Department of Population Health, University of Oxford; an International Fellow at the Population Health Research Institute, University of McMaster (Canada); and a consultant neurologist in NHS Lothian, working with patients with stroke and dementia.
His work seeks to elucidate the mechanisms for prevention of disability due to stroke and dementia through the design, delivery and analysis of epidemiological studies and clinical trials. Of particular interest are: the contribution of vascular risk factors to dementia; the very long term follow-up of randomized trials; and the better use of large electronic health record datasets for more efficient clinical trials and cohort studies.
He has founded and run the Edinburgh Stroke Winter School www.ed.ac.uk/clinical-brain-sciences/postgraduate-training/edinburgh-stroke-winter-school. His work has been supported by the UK MRC (Clinician Scientist fellowship 2010-2015), the Chief Scientist’s Office (2006-2009, 2018-2025), and the Stroke Association.
Research summary
- Contribution of known vascular risk factors to dementia
- Acute treatment of ischaemic stroke
- Development of novel methods for large scale trials with electronic health records
-
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
In:
Lancet Neurology
DOI: https://doi.org/10.1016/S1474-4422(19)30184-X
Contribution to journal › Article (E-pub ahead of print) -
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
In:
Lancet Neurology
DOI: https://doi.org/10.1016/S1474-4422(19)30184-X
Contribution to journal › Article (E-pub ahead of print) -
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
In:
The Lancet
DOI: https://doi.org/10.1016/S0140-6736(19)30840-2
Contribution to journal › Article (Published) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage : statistical analysis plan for a randomised controlled trial
In:
Trials, vol. 20, no. 1, pp. 183
DOI: https://doi.org/10.1186/s13063-019-3270-2
Contribution to journal › Article (Published) -
Clinical diagnosis of TIA or minor stroke and prognosis in patients with neurological symptoms: : A rapid access clinic cohort
In:
PLoS ONE, vol. 14, no. 3
DOI: https://doi.org/10.1371/journal.pone.0210452
Contribution to journal › Article (Published)